Saturday, October 3, 2026

EUR/CHF Bearish By 1% In The Last 10 Sessions

ViaNews Editorial Team

October 16, 2023

EUR/CHF Bearish By 1% In The Last 10 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.27% for the last 10 sessions. At 02:06 EST on Monday, 16 October, EUR/CHF (EURCHF) is $0.95.

EUR/CHF's yearly highs and lows, it's 0.306% up from its 52-week low and 5.942% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.23%, a positive 0.01%, and a positive 0.23%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.31% (last week), 0.26% (last month), and 0.23% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be overbought (>=80).

News about

  • We maintain a forecast of eur/usd 1.02 on a 3-month view – rabobank. According to FXStreet on Saturday, 14 October, "Jane Foley, the Senior FX Strategist and Head of FX Strategyat Rabobank's RaboResearch is out with a note highlighting the risk for a deterioration in Euro-area economics, seeing a case for the EUR/USD to reach 1.02 over the next quarter."
  • Eur/usd falters on Friday, backsliding into 1.05. According to FXStreet on Saturday, 14 October, "On the daily candles, the EUR/USD is getting rejected from a descending trendline, and facing further bearish momentum after failing to capture the 1.0600 handle. ", "The EUR/USD pinged 1.0500 in Friday's downside push, with European production figures spreading to the middle,and the European Central Bank's (ECB) President Christine Lagarde reaffirmed the ECB's tight monetary policy stance until inflation achieves the central bank's 2% target."
  • According to FXStreet on Monday, 16 October, "At the time of writing, EUR/USD is trading near 1.0518, holding higher while adding 0.07% on the day"
  • Eur/usd trades with mild positive bias above 1.0500 mark, lacks bullish conviction. According to FXStreet on Monday, 16 October, "The US Dollar (USD) struggles to capitalize on its post-US CPI gains registered over the past two trading days and oscillates in a range during the Asian session on Monday, which, in turn, is seen lending some support to the EUR/USD pair. ", "However, speculations that further rate hikes by the European Central Bank (ECB) may be off the table for now cap gains for the EUR/USD pair."

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com